Eli Lilly Boosts Its Outlook on High Demand for Popular Weight-Loss Drugs
The drugmaker hiked its guidance as sales soared for its popular weight-loss drugs Zepbound and Mounjaro.
30 Oct 14:46 · Investopedia
Eli Lilly says weight-loss pill a candidate for speedy approval under new US program
Eli Lilly said on Thursday its experimental weight-loss pill met most criteria for the U.S. Food and Drug Administration's new national priority voucher.
31 Oct 00:36 · KSL.com
last updated on 31 Oct 06:03